Peter Branagan
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- SARS-CoV-2 detection and testing
-
- Cystic Fibrosis Research Advances
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory and Cough-Related Research
- Inhalation and Respiratory Drug Delivery
- Chronic Obstructive Pulmonary Disease (COPD) Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Cystic Fibrosis Research Advances 3
-
- Antifungal resistance and susceptibility 4
- Co-authors
- Noel G. McElvaney (10 shared papers)Sanjay H. Chotirmall (6 shared papers)Cedric Gunaratnam (6 shared papers)Catherine M. Greene (1 shared paper)P M Logan (1 shared paper)Michelle A. McMahon (1 shared paper)Brian McCullagh (1 shared paper)Michael R. Watts (1 shared paper)
- Journals
- Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation (2 papers)Journal of the American Geriatrics Society (1 paper)European Journal of Radiology (1 paper)Journal of Nutrition and Metabolism (1 paper)Expert Opinion on Therapeutic Targets (1 paper)
- Partner nations
- IrelandAustraliaUnited Kingdom
In The Last Decade
Peter Branagan
15 papers receiving 269 citations
Peers
Comparison fields: 5 of 64
- Infectious Diseases 115
- Pulmonary and Respiratory Medicine 184
- Physiology 82
- Emergency Medical Services 11
- Immunology and Allergy 9
Countries citing papers authored by Peter Branagan
This map shows the geographic impact of Peter Branagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Branagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Branagan more than expected).
Fields of papers citing papers by Peter Branagan
This network shows the impact of papers produced by Peter Branagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Branagan. The network helps show where Peter Branagan may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Branagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 57 | |
| 2 | 2011 | 49 | |
| 3 | 2008 | 40 | |
| 4 | 2009 | 40 | |
| 5 | Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis. | 2015 | 36 |
| 6 | 2008 | 29 | |
| 7 | 1985 | 13 | |
| 8 | 2016 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 2 | |
| 11 | 2006 | 2 | |
| 12 | Aspergillosis in a chest hospital. | 1980 | 1 |
| 13 | 2009 | 1 | |
| 14 | Male fertility in cystic fibrosis. | 2010 | 1 |
| 15 | The diagnosis and treatment of constrictive pericarditis. | 1983 | 1 |
| 16 | 2018 | 1 | |
| 17 | 2012 | 0 |
About Peter Branagan
Peter Branagan is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 280 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cystic Fibrosis Research Advances (3 papers), Mycobacterium research and diagnosis (2 papers), Biochemical and Structural Characterization (2 papers), Protease and Inhibitor Mechanisms (2 papers), Peptidase Inhibition and Analysis (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Infectious Diseases (115 citations), Pulmonary and Respiratory Medicine (184 citations), Physiology (82 citations), Emergency Medical Services (11 citations) and Immunology and Allergy (9 citations). Peter Branagan has collaborated with scholars based in Ireland, Australia and United Kingdom. Frequent co-authors include Noel G. McElvaney, Sanjay H. Chotirmall, Cedric Gunaratnam, Catherine M. Greene, P M Logan, Michelle A. McMahon, Brian McCullagh, Michael R. Watts, Michael T. Henry and Muhammad Haroon. Their work appears in journals such as Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, Journal of the American Geriatrics Society, European Journal of Radiology, Journal of Nutrition and Metabolism and Expert Opinion on Therapeutic Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.